PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.56%
Revenue growth under 50% of 2127.T's 13.80%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.69%
Gross profit growth under 50% of 2127.T's 34.91%. Michael Burry would be concerned about a severe competitive disadvantage.
5.94%
EBIT growth below 50% of 2127.T's 44.57%. Michael Burry would suspect deeper competitive or cost structure issues.
0.67%
Operating income growth under 50% of 2127.T's 64.98%. Michael Burry would be concerned about deeper cost or sales issues.
-4.69%
Negative net income growth while 2127.T stands at 54.23%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-4.70%
Negative EPS growth while 2127.T is at 54.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.70%
Negative diluted EPS growth while 2127.T is at 51.02%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.03%
10Y revenue/share CAGR under 50% of 2127.T's 237.13%. Michael Burry would suspect a lasting competitive disadvantage.
-7.20%
Negative 5Y CAGR while 2127.T stands at 382.13%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.91%
Negative 3Y CAGR while 2127.T stands at 190.94%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
24.45%
Below 50% of 2127.T's 294.21%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
15.10%
Below 50% of 2127.T's 815.91%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-43.23%
Negative 3Y CAGR while 2127.T is 332.38%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
33.35%
Below 50% of 2127.T's 183.97%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-12.89%
Negative 3Y equity/share growth while 2127.T is at 103.17%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-99.40%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.08%
We show growth while 2127.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.93%
Positive asset growth while 2127.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.20%
1.25-1.5x 2127.T's 3.57%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-34.68%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
82.29%
We expand SG&A while 2127.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.